Can pharma respond to the QIPP agenda?
28 Feb 2010
Mike Sobanja, Chief Executive, NHS Alliance and Andy Etheridge, Commercial Director, Cegedim Dendrite, outline the challenges facing pharma in adapting to the recommendations of QIPP, the expected rationalisation of PCTs and the predicted emergence of GP consortia led Practice Based Commissioning.
Read More